Day 1
Monday, September 14, 2026
Opening Remarks
Rakesh Jain
10:00-10:10 am
Tumor Microenvironment I: Angiogenesis and Vascular Function
Rakesh Jain
10:10-11:20 am
Q&A
Rakesh Jain; Dai Fukumura
11:20-11:35 am
Break
11:35-11:50 am
Tumor Microenvironment II: Vascular Normalization and Immunotherapy
Rakesh Jain
11:50 am-1:10 pm
Q&A
Rakesh Jain; Dai Fukumura
1:10-1:25 pm
Lunch Break
1:25-2:25 pm
Tumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis
Rakesh Jain
2:25-3:45 pm
Q&A
Rakesh Jain; Dai Fukumura
3:45-4:00 pm
Break
4:00-4:30 pm
Cancer Immunology and Immunotherapy Overview
Arlene Sharpe
4:30-5:35 pm
Q&A
Arlene Sharpe; Zohreh Amoozgar
5:35-5:50 pm
Day 2
Tuesday, September 15, 2026
Skull Bone Marrow as a Site for Immuno- Surveillance of Healthy Brain and Brain Tumors
Jonathan Kipnis
10:00-11:05 am
Q&A
Marc Charbati
11:05-11:20 am
Break
11:20-11:50 am
Neuron-Cancer Interactions in the TME *pre-recorded
Michelle Monje
11:50 am-12:55 pm
Q&A
Anna Geraghty
12:55-1:10 pm
Break
1:10-2:10 pm
Determinants of How Tumors Use Metabolism to Support Growth
Matthew Vander Heiden
2:10-3:15 pm
Q&A
Sonu Subudhi
3:15-3:30 pm
Break
3:30-4:00 pm
Emerging Strategies to Improve CAR-T cell Therapy for Glibolastoma and other Solid Tumors
Hideho Okada
4:00-5:05 pm
Q&A
Sumedha Pareek
5:05-5:20 pm
Day 3
Wednesday, September 16, 2026
AI in Basic and Clinical Oncology
Eliezer Van Allen
10:00-11:05 am
Q&A
Sonu Subudhi
11:05-11:20 am
Break
11:20-11:50 am
Dissecting the Ecosystem of Gliomas by Single-Cell and Spatial Genomics
Mario Suva
11:50 am-12:55 pm
Q&A
Daniel Radin
12:55-1:10 pm
Lunch Break
1:10-2:30 pm
Mechanisms of the Gut Microbiome from Biomarker to Immunotherapy Adjuvant
Bertrand Routy
2:30-3:30 pm
Q&A
Benjamin Wolf
3:30-3:45 pm
Break
3:45-4:00 pm
RREBELLIOUS INTERFERENCE: Challenging old paradigms and discovering new strategies for targeting pediatric brain tumors
Robert Wechsler-Reya
4:00-5:05 pm
Q&A
Taylor Uccello
5:05-5:20 pm
Day 4
Thursday, September 17, 2026
Fibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer
David Tuveson
10:00-11:05 am
Q&A
Heena Kumra
11:05-11:20 am
Break
11:20-11:50 am
Metastasis Ecosystems
Joan Massague
11:50 am-12:55 pm
Q&A
Lei Xu
12:55-1:10 pm
Break
1:10-2:10 pm
Identifying Immune Vulnerabilities in Solid Tumors *pre-recorded
Lisa Coussens
2:10-3:15 pm
Q&A
Sumedha Pareek
3:15-3:30 pm
Break
3:30-4:00 pm
Circadian Clock and Metabolic Vulnerabilities of Cancer
Chi Dang
4:00-5:05 pm
Q&A
Melin Khandekar
5:05-5:20 pm
Summary and Closing Remarks
Rakesh Jain
5:20-5:30 pm